Oragenics Inc. (OGEN) Stock Price

OGENStock
$0.5252.77%52W
Market Cap$2.35M
P/E
PEG Ratio-8.96
Div yield
Beta1.29

OGEN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-38.95%
Price vs S&P 500 (4W)1.48%
PEG Ratio-8.96
VGM Score26.76

OGEN Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.14
4.14
4.14
4.14

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
OGENOragenics Inc.
D$0.52
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Oragenics Inc.

Oragenics Inc develops nasal-delivery pharmaceutical treatments for neurology and infectious diseases. The company's lead candidate, ONP-002, is a synthetic neurosteroid designed to cross the blood-brain barrier and rapidly reduce inflammation, swelling, and oxidative stress. ONP-002 is being developed to treat concussions by restoring proper blood flow.